These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 483230)

  • 1. The Canadian cooperative study of platelet suppressant therapy in threatened stroke.
    Gent M
    Thromb Haemost; 1979 Feb; 41(1):163-70. PubMed ID: 483230
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial of aspirin and sulfinpyrazone in patients with threatened stroke. Results and methodologic issues.
    Gent M; Barnett HJ; Sackett DL; Taylor DW
    Circulation; 1980 Dec; 62(6 Pt 2):V97-105. PubMed ID: 7002357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
    Friedman LM
    Circulation; 1980 Dec; 62(6 Pt 2):V88-9. PubMed ID: 7002355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
    Sherry S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
    [No Abstract]   [Full Text] [Related]  

  • 5. [Controversy on platelet-inhibiting drugs].
    Oelz O
    Schweiz Med Wochenschr; 1985 May; 115(20):703-7. PubMed ID: 3892659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical appraisal of the clinical efficiency of anti-platelet drugs.
    Lecompte T; Samama M
    Agents Actions Suppl; 1986; 20():203-14. PubMed ID: 3544741
    [No Abstract]   [Full Text] [Related]  

  • 7. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized trial of therapy with platelet antiaggregants for threatened stroke.
    The Canadian Cooperative Stroke Study Group
    Can Med Assoc J; 1980 Feb; 122(3):293-6. PubMed ID: 6989457
    [No Abstract]   [Full Text] [Related]  

  • 9. The Canadian trial of aspirin and sulfinpyrazone in threatened stroke.
    Whisnant JP
    Am Heart J; 1980 Jan; 99(1):129-30. PubMed ID: 6985763
    [No Abstract]   [Full Text] [Related]  

  • 10. Preventing stroke.
    Br Med J; 1978 Aug; 2(6135):454-5. PubMed ID: 354745
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"].
    Inzitari D; Fratiglioni L; Baldereschi M; Candelise L; Anzalone N; Bonatti ML; Prencipe M; Gandolfo C; Mamoli A; Rasura M
    Epidemiol Prev; 1990 Jun; 12(43):6-11. PubMed ID: 2149110
    [No Abstract]   [Full Text] [Related]  

  • 12. The Canadian trial of aspirin and sulfinpyrazone in threatened stroke.
    N Engl J Med; 1978 Oct; 299(17):953-5. PubMed ID: 357975
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet suppressing drugs in arterial disease.
    Blakely JA
    Thromb Haemost; 1978 Apr; 39(2):294-303. PubMed ID: 580983
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiplatelet therapy.
    Turpie AG
    Clin Haematol; 1981 Jun; 10(2):497-520. PubMed ID: 7032786
    [No Abstract]   [Full Text] [Related]  

  • 15. Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
    Harker LA; Hirsh J; Gent M; Genton E
    Prog Hematol; 1975; 9():229-54. PubMed ID: 766074
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet-inhibitory therapy in reconstructive arterial surgery.
    McCollum CN; Goldman M
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():301-9. PubMed ID: 3159216
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiplatelet therapy and cerebrovascular diseases.
    Meloche JP
    Adv Otorhinolaryngol; 1982; 28():100-3. PubMed ID: 7051785
    [No Abstract]   [Full Text] [Related]  

  • 18. Controversy in neurology: the Canadian study on TIA and aspirin. A critique of the Canadian TIA study. Reply.
    Barnett HJ; Gent M; Sackett DL; Taylor DW
    Ann Neurol; 1979 Jun; 5(6):599-601. PubMed ID: 382979
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: The effect of a platelet inhibiting drug (sulfinpyrazone) in the therapy of patients with transient ischemic attacks (Tia's) and minor strokes.
    Robertson JT; Dugdale M; Salky N; Robinson H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):598. PubMed ID: 1105880
    [No Abstract]   [Full Text] [Related]  

  • 20. The current status of platelet suppressive drugs in the treatment of thrombosis.
    Hirsh J; Gent M; Genton E
    Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.